论文信息 - Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: an uncommon adverse effect?

Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: an uncommon adverse effect?

1 Department of Dermatology, Maebashi Red Cross Hospital, Maebashi, Gunma, Japan 2 Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan 3 Department of Dermatology, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi, Japan 4 Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan Naoko MORIMOTO1 Akira SHIMIZU2 Kazunori OHNISHI1 Yutaka SHIMOMURA3,4

[1] F. Galimberti,et al. Sarcoidosis following successful treatment of pemphigus vulgaris with rituximab: a rituximab‐induced reaction further supporting B‐cell contribution to sarcoidosis pathogenesis? , 2016, Clinical and experimental dermatology.

[2] N. Shear,et al. Granulomatous Drug Eruptions. , 2015, Dermatologic clinics.

[3] V. Ruocco,et al. Cutaneous sarcoidosis: an intriguing model of immune dysregulation , 2015, International journal of dermatology.

[4] J. Cardoso,et al. The “Mystery” of Cutaneous Sarcoidosis: Facts and Controversies , 2014, International journal of immunopathology and pharmacology.

[5] I. Ueda‐Hayakawa,et al. Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity. , 2013, Rheumatology.

[6] G. Hoffman,et al. Sarcoidosis and systemic vasculitis. , 2000, Seminars in arthritis and rheumatism.

[7] R. Panush. Rituximab versus cyclophosphamide for ANCA-associated vasculitis , 2011 .